Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis

American Journal of Clinical Nutrition

Volumn 79, Issue 3, 2004, Pages 362-371

  Holick, Michael F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

25 hydroxyvitamin D; Bone health; Cancer; Diabetes; Sunlight; Vitamin D

Indexed keywords

CALCIFEDIOL; COLECALCIFEROL; VITAMIN D; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE;

BIOLOGICAL MONITORING; BREAST FEEDING; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DIETARY INTAKE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ORANGE JUICE; OSTEOPOROSIS; SKIN PIGMENTATION; SKIN PROTECTION; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; HEART DISEASE; INFANT; INFANT NUTRITION; NEOPLASM; NUTRITIONAL REQUIREMENT; PHOTOSYNTHESIS; PHYSIOLOGY; REVIEW; SEASON; SUNLIGHT;

ANIMALIA;

BREAST FEEDING; DIABETES MELLITUS, TYPE 1; HEART DISEASES; HUMANS; INFANT; INFANT NUTRITION PHYSIOLOGY; NEOPLASMS; NUTRITIONAL REQUIREMENTS; OSTEOPOROSIS; PHOTOSYNTHESIS; SEASONS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 1642281100     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/79.3.362     Document Type: Conference Paper

References (74)

1. Holick MF. Phylogenetic and evolutionary aspects of vitamin D from phytoplankton to humans. In: Pang PKT, Schreibman MP, editors. Vertebrate endocrinology: fundamentals and biomedical implications. Vol 3. Orlando: Academic Press, 1989:7-43.
2. Holick MF. Vitamin D. A millenium perspective. J Cell Biochem 2003;88:296-307.
3. Morris JG, Earle KE. Vitamin D and calcium requirements of kittens. Vet Clin Nutr 1996;3:93.
4. 3 supplementation on mineral homeostasis in a subterranean mole-rat Cryptomys damarensis. Bone Miner 1994;27:145-57.
5. How KL, Hazewinkel HAW, Mol JA. Dietary vitamin D dependence of cat and dog due to inadequate cutaneous synthesis of vitamin D. Gen Comp Endocrinol 1994;96:12-8.
6. Velluz L, Amiard G, Petit A. Le precalciferol - ses relations d'equilibre avec le calciferol. [Precalciferol and its relationship of equilibrium with calciferol.] Bull Soc Chim Fr 1949;16:501-8(in French).
7. 3 in the skin of poikilothermic animals. Proc Natl Acad Sci U S A 1995;92:3124-6.
8. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993;91:2552-5.
9. Holick MF. Vitamin D. The underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002;9:87-98.
10. 3 synthesis. J Clin Endocrinol Metab 1987;64:1165-8.
11. Holick MF. McCollum Award Lecture, 1994: vitamin D - new horizons for the 21st century. Am J Clin Nutr 1994;60:619-30.
12. 3. Lancet 1982;1:74-6.
13. 3 synthesis in human skin. J Clin Endocrinol Metab 1988;67:373-8.
14. 3 in cities around the world. In: Holick MF, Kligman A, eds. Biologic effects of light. Symposium proceedings, October 13-15, 1991. Berlin: Walter De Gruyter & Company, 1992:48-51.
15. Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. Fortification of orange juice with vitamin D: a novel approach to enhance vitamin D nutritional health. Am J Clin Nutr 2003;77:1478-83.
16. 3. J Clin Invest 1985;76:1536-8.
17. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet 1989;1:1104-5.
18. Reid IR, Gallagher DJA, Bosworth J. Prophylaxis against vitamin D deficiency in the elderly by regular sunlight exposure. Age Aging 1985;15:35-40.
19. Chuck A, Todd J, Diffey B. Subliminal ultraviolet-B irradiation for the prevention of vitamin D deficiency in the elderly: a feasibility study. Photochem Photoimmunol Photomed 2001;17:168-71.
20. Specker B, Tsang RC, Hollis BW. Effect of race and diet on human-milk vitamin D and 25-hydroxyvitamin D. Am J Dis Child 1985;139:1134-7.
21. Kreiter SR, Schwartz RP, Kirkman HN, Charlton PA, Calikoglu AS, Davenport M. Nutritional rickets in African American breast-fed infants. J Pediatr 2000;137:2-6.
22. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002;76:187-92.
23. Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002;112:659-62.
24. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985;76:370-3.
25. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3.
26. Holick MF. Sunlight and vitamin D: both good for cardiovascular health. J Gen Intern Med 2002;17:733-5.
27. Holick MF. Sunlight "D"ilemma: risk of skin cancer or bone disease and muscle weakness. Lancet 2001;357:4-6.
28. Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000;247:260-8.
29. Glerup H, Middelsen K, Poulsen L, et al. Hypovitaminosis D myopathy without biochemical signs of ostemalacia bone involvement. Calcif Tissue Int 2000;66:419-24.
30. Brown EM, Pollak M, Seidman CE, et al. Calcium-ion-sensing cell-surface receptors. N Engl J Med 1995;333:234-40.
31. Holick MF. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 5th ed. Washington, DC: American Society for Bone and Mineral Research, 2003:129-37.
32. Juppner H, Kronenberg HM. Parathyroid hormone. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 5th ed. Washington, DC: American Society for Bone and Mineral Research, 2003:117-24.
33. Garland CF, Garland FC, Shaw EK, Comstock GW, Helsing KJ, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989;1:1176-8.
34. Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990;19:614-2.
35. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and pre-diagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000;11:847-52.
36. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992;70:2861-9.
37. Apperly FL. The relation of solar radiation to cancer mortality in North America. Cancer Res 1941;1:191-5.
38. Grant WB. An estimate of premature cancer mortality in the U. S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002;94:1867-75.
39. Holick MF, Jenkins M. The UV advantage. New York: iBooks, Inc (in press).
40. Hernán MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999;51:1711-8.
41. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1979;30:150-6.
42. Grant WB. An ecologic study of the role of solar UV-B radiation in reducing the risk of cancer using cancer mortality data, dietary supply data and latitude for European countries. In: Holick MF, editor. Biologic effects of light 2001 (proceedings of a symposium, Boston, MA). Boston: Kluwer Academic Publishing, 2002:267-6.
43. Grant WB. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 2002;94:272-81.
44. Bodiwala D, Luscombe CJ, Liu S, Saxby M, French M, Jones PW. Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlight. Cancer Lett 2003;192:145-9.
45. DeLuca HF, Cantoma MT. Vitamin D: its role and uses in immunology. FASEB J 2001;15:2579-85.
46. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979;206:1188-90.
47. 3 and the immune system. Mol Cell Endocrinol 1985;43:113-22.
48. 3 analogs as immunomodulatory agents. Trends Mol Med 2002;8:174-9.
49. Feldman D, Zhao XY, Krishnan AV. Vitamin D and prostate cancer. Endocrinology 2000;141:5-9.
50. 3 and its analogues in the treatment of psoriasis. Retinoids 1998;14:12-7.
51. 3 analogue (MC903) in a double-blind study. Br J Dermatol 1988;119:223-30.
52. 3 analog enhances regulatory t-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002;51:1367-74.
53. Cantorna MT, Hayes CE, DeLuca HF. 1, 25-Dihydroxyholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998;128:68-72.
54. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 1996;93:7861-4.
55. 3. Diabetologia 1994;37:552-8.
56. Hypponen E, Laara E, Jarvelin M-R, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-3.
57. Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet 1998;352:709-10.
58. Li Y, Kong J, Wei M, Chen ZF, Liu S, Cao LP. 1, 25-dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-38.
59. Adams JA, Clemens TL, Parrish JA, Holick MF. Vitamin D synthesis and metabolism after ultraviolet radiation of normal and vitamin D deficient subjects. N Engl J Med 1981;306:722-5.
60. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol responses to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-10.
61. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56.
62. 3 in vitro synthesis by human decidua and placenta. Nature 1979;281:317-9.
63. 3 production by human keratinocytes: kinetics and regulation. J Clin Invest 1986;78:557-66.
64. 3. Cancer Epidemiol Biomarkers Prev 1998;7:391-5.
65. Tangpricha V, Flanagan JN, Whitlatch LW, et al. 25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue. Lancet 2001;357:1673-4.
66. 3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 2001;66:287-92.
67. 3 by a human small cell lung cell line. J Clin Endocrinol Metab 1994;79:554-60.
68. 3 in vivo. Science 1976;193:493-4.
69. Holick MF. Vitamin D. In: Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: Institute of Medicine. National Academy Press, 1997:250-87.
70. Heaney RP. Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr 2003;78:912-9.
71. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;22:142-6.
72. Koutkia P, Lu Z, Chen TC, Holick MF. Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation. Gastroenterology 2001;121:1485-8.
73. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003;41:105-12.
74. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805-6.